Understanding the Qualifying Conditions for a Medical Marijuana Card in Pennsylvania, Ohio, and West Virginia: Insights into the Medical Marijuana...
EMA’s CHMP Declines Renewal of Translarna and Rejects Nezglyal and Syfovre as New Medicines The European Medicines Agency’s (EMA) Committee...
Former Bayer R&D Chief Assumes CEO Role at BenevolentAI In a significant move for the pharmaceutical industry, Dr. Joerg Moeller,...
A Study Investigating a Potential Novel Therapy for ALS: Proof-of-Concept Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease,...
Novartis, a leading pharmaceutical company, has recently announced a significant strengthening of its partnership with Voyager Therapeutics, a gene therapy...
Zevra Therapeutics, a biopharmaceutical company focused on developing innovative treatments for rare and neurodegenerative diseases, has recently resubmitted its New...
BrainStorm Cell Therapeutics, a leading biotechnology company, has recently been granted patents for its allogeneic exosome platform-product in the treatment...
Cytokinetics, a biopharmaceutical company focused on the development of muscle activators and inhibitors, is rapidly approaching a crucial deadline in...
Efficient Method for Creating a Self-Organizing Neuromuscular Junction Model from Human Pluripotent Stem Cells – Findings in Nature Communications In...
Efficient creation of a model of self-organizing neuromuscular junction using human pluripotent stem cells – Findings from Nature Communications The...
Efficient creation of a model of self-organizing neuromuscular junction using human pluripotent stem cells – Insights from Nature Communications The...
Efficient creation of a model of self-organizing neuromuscular junction using human pluripotent stem cells – Findings in Nature Communications Researchers...
In the world of pharmaceuticals and medical research, there are always exciting developments and breakthroughs that capture the attention of...
The California Institute for Regenerative Medicine (CIRM) has recently announced the allocation of $17.5 million for clinical-stage research, with a...
Biotech Company Supported by Forbion Secures $138M Funding for ALS Drug Development In a significant boost to the fight against...
